SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002644
Filing Date
2020-04-28
Accepted
2020-04-28 16:09:26
Documents
3
Period of Report
2020-06-18
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241464zdef14a.htm DEF 14A 755864
2 G19952BII001.JPG g19952bii001.jpg GRAPHIC 153459
3 G19952BII002.JPG g19952bii002.jpg GRAPHIC 122406
  Complete submission text file 0001047469-20-002644.txt   1137179
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 20825071
SIC: 2835 In Vitro & In Vivo Diagnostic Substances